Literature DB >> 3150973

Immunochemical and biochemical comparisons between embryonic chick bone marrow and epiphyseal cartilage chondroitin/dermatan sulphate proteoglycans.

J M Sorrell1, F Mahmoodian, B Caterson.   

Abstract

Chrondroitin sulphate proteoglycans obtained from embryonic chick bone marrow and epiphyseal cartilage were compared using immunochemical and biochemical analyses. Proteoglycans from each tissue, separated on CsCl density gradients, under dissociative conditions, into high (1.6 g ml-1), medium (1.5 g ml-1) and low (1.4 g ml-1) buoyant density fractions, were immunochemically analysed, using a panel of monoclonal antibodies that specifically recognize chondroitin 4-/dermatan sulphates, chondroitin 6-sulphate, keratan sulphate, the hyaluronate binding region present on connective tissue proteoglycans, and link protein. The same antibodies were used in Western blot analyses to detect intact proteoglycan monomers and core proteins that had been fractionated by agarose-polyacrylamide and by sodium dodecyl sulphate-polyacrylamide gel electrophoresis. Specific differences between marrow and cartilage proteoglycans were detected. In CsCl gradients, marrow proteoglycans displayed a higher degree of heterogeneity in terms of buoyant densities and hexuronate distribution. Keratan sulphate chains were constituents of the majority of 'large' proteoglycans in the marrow; however, a portion of the large proteoglycans in marrow middle buoyant density fraction either lacked keratan sulphate chains or were substituted with a form different from that found on cartilage proteoglycans. Marrow lacked 'small' chondroitin/dermatan sulphate proteoglycans that were present in cartilage and contained a more heterogeneous population of proteoglycans, particularly in the lower buoyant density fractions. Both marrow and cartilage were similar in that they contained, as their major components, large, aggregating proteoglycans and link proteins that were immunochemically and biochemically identical. The significance of these differences between marrow and cartilage proteoglycans remains to be determined, but they may, in part, be responsible for imparting unique characteristics to the haematopoietic extracellular matrices.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3150973     DOI: 10.1242/jcs.91.1.81

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  5 in total

1.  Fell-Muir Lecture: chondroitin sulphate glycosaminoglycans: fun for some and confusion for others.

Authors:  Bruce Caterson
Journal:  Int J Exp Pathol       Date:  2012-02       Impact factor: 1.925

2.  Spatiotemporal Expression of 3-B-3(-) and 7-D-4 Chondroitin Sulfation, Tissue Remodeling, and Attempted Repair in an Ovine Model of Intervertebral Disc Degeneration.

Authors:  Brooke Farrugia; Susan M Smith; Cindy C Shu; James Melrose
Journal:  Cartilage       Date:  2019-10-03       Impact factor: 4.634

Review 3.  Losing the sugar coating: potential impact of perineuronal net abnormalities on interneurons in schizophrenia.

Authors:  Sabina Berretta; Harry Pantazopoulos; Matej Markota; Christopher Brown; Eleni T Batzianouli
Journal:  Schizophr Res       Date:  2015-01-16       Impact factor: 4.939

4.  Proteoglycan-targeted antibodies as markers on non-Hodgkin lymphoma xenografts.

Authors:  L Kopper; A Bankfalvi; R Mihalik; T T Glant; J Timar
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

5.  Aggrecan and chondroitin-6-sulfate abnormalities in schizophrenia and bipolar disorder: a postmortem study on the amygdala.

Authors:  H Pantazopoulos; M Markota; F Jaquet; D Ghosh; A Wallin; A Santos; B Caterson; S Berretta
Journal:  Transl Psychiatry       Date:  2015-01-20       Impact factor: 6.222

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.